Evolus - 1 Year Stock Price History | EOLS

Historical daily share price chart and data for Evolus since 2018 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Evolus as of January 22, 2019 is 16.24.
Evolus Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 15.3500 12.4300 16.2800 12.4300 16.2400 36.47%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.443B $0.000B
Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $125.560B 25.44
Medtronic (MDT) Ireland $116.845B 17.47
Stryker (SYK) United States $62.070B 23.40
Boston Scientific (BSX) United States $51.560B 26.06
Baxter (BAX) United States $37.069B 23.94
Zimmer Biomet Holdings (ZBH) United States $21.197B 13.75
ResMed (RMD) United States $16.739B 31.92
Smith & Nephew SNATS (SNN) United Kingdom $16.480B 0.00
Canopy Growth (CGC) Canada $10.136B 0.00
Bio-Rad Laboratories (BIO) United States $7.056B 45.12
Hill-Rom Holdings (HRC) United States $6.447B 20.36
Aurora Cannabis (ACB) Canada $6.178B 32.58
Perrigo (PRGO) Ireland $6.105B 9.27
Haemonetics (HAE) United States $5.072B 44.61
ICU Medical (ICUI) United States $4.894B 27.27
Insulet (PODD) United States $4.517B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.200B 0.00
Neogen (NEOG) United States $3.138B 48.21
Agios Pharmaceuticals (AGIO) United States $3.041B 0.00
Hutchison China MediTech (HCM) China $2.918B 0.00
National Vision Holdings (EYE) United States $2.467B 47.72
NuVasive (NUVA) United States $2.457B 22.87
Quidel (QDEL) United States $2.042B 26.63
NxStage Medical (NXTM) United States $1.891B 0.00
Aphria (APHA) $1.768B 78.67
Phibro Animal Health (PAHC) United States $1.259B 17.82
AtriCure (ATRC) United States $1.203B 0.00
VAREX IMAGING (VREX) United States $1.038B 20.79
Cardiovascular Systems (CSII) United States $1.001B 1441.00
PetIQ (PETQ) United States $0.788B 20.43
Cerus (CERS) United States $0.764B 0.00
OraSure Technologies (OSUR) United States $0.739B 41.59
Meridian Bioscience (VIVO) United States $0.703B 22.42
Omeros (OMER) United States $0.651B 0.00
Surmodics (SRDX) United States $0.645B 97.61
Eagle Pharmaceuticals (EGRX) United States $0.627B 20.11
Lantheus Holdings (LNTH) United States $0.625B 19.36
NanoString Technologies (NSTG) United States $0.623B 0.00
MacroGenics (MGNX) United States $0.487B 0.00
Owens & Minor (OMI) United States $0.481B 5.44
Quanterix (QTRX) United States $0.449B 0.00
LeMaitre Vascular (LMAT) United States $0.449B 22.04
TG Therapeutics (TGTX) United States $0.361B 0.00
Utah Medical Products (UTMD) United States $0.314B 20.31
Insys Therapeutics (INSY) United States $0.305B 0.00
Bovie Medical (APYX) United States $0.280B 0.00
Vapotherm (VAPO) United States $0.273B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.268B 0.00
Cytosorbents (CTSO) United States $0.230B 0.00
BioLife Solutions (BLFS) United States $0.229B 310.00
Rockwell Medical (RMTI) United States $0.178B 0.00
Fonar (FONR) United States $0.137B 6.88
Chimerix (CMRX) United States $0.132B 0.00
Surface Oncology (SURF) United States $0.132B 0.00
Chembio Diagnostics (CEMI) United States $0.120B 0.00
United-Guardian (UG) United States $0.086B 18.00
Female Health (VERU) United States $0.085B 0.00
InfuSystems Holdings (INFU) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 16.73
Oramed Pharmaceuticals (ORMP) United States $0.059B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Neurotrope (NTRP) United States $0.031B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.020B 0.00
Senestech (SNES) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00